These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 23648450)

  • 1. Galectin-9 in tumor biology: a jack of multiple trades.
    Heusschen R; Griffioen AW; Thijssen VL
    Biochim Biophys Acta; 2013 Aug; 1836(1):177-85. PubMed ID: 23648450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Galectins in Tumors and in Clinical Immunotherapy.
    Chou FC; Chen HY; Kuo CC; Sytwu HK
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-9 in cancer therapy.
    Fujihara S; Mori H; Kobara H; Rafiq K; Niki T; Hirashima M; Masaki T
    Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):130-7. PubMed ID: 23514536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Therapy Due to Apoptosis: Galectin-9.
    Fujita K; Iwama H; Oura K; Tadokoro T; Samukawa E; Sakamoto T; Nomura T; Tani J; Yoneyama H; Morishita A; Himoto T; Hirashima M; Masaki T
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28045432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling galectin-1 as a novel therapeutic target for cancer.
    Astorgues-Xerri L; Riveiro ME; Tijeras-Raballand A; Serova M; Neuzillet C; Albert S; Raymond E; Faivre S
    Cancer Treat Rev; 2014 Mar; 40(2):307-19. PubMed ID: 23953240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Galectins in Resistance to Anticancer Therapies.
    Navarro P; Martínez-Bosch N; Blidner AG; Rabinovich GA
    Clin Cancer Res; 2020 Dec; 26(23):6086-6101. PubMed ID: 32709716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular galectins: regulators of tumor progression and targets for cancer therapy.
    Thijssen VL; Rabinovich GA; Griffioen AW
    Cytokine Growth Factor Rev; 2013 Dec; 24(6):547-58. PubMed ID: 23942184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Galectins in Multiple Myeloma.
    Storti P; Marchica V; Giuliani N
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular galectins in cancer cells: potential new targets for therapy (Review).
    Vladoiu MC; Labrie M; St-Pierre Y
    Int J Oncol; 2014 Apr; 44(4):1001-14. PubMed ID: 24452506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies.
    van Beijnum JR; Thijssen VL; Läppchen T; Wong TJ; Verel I; Engbersen M; Schulkens IA; Rossin R; Grüll H; Griffioen AW; Nowak-Sliwinska P
    Int J Cancer; 2016 Aug; 139(4):824-35. PubMed ID: 27062254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of Galectin-7 in Cancer.
    Kaur M; Kaur T; Kamboj SS; Singh J
    Asian Pac J Cancer Prev; 2016; 17(2):455-61. PubMed ID: 26925627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target.
    Smetana K; André S; Kaltner H; Kopitz J; Gabius HJ
    Expert Opin Ther Targets; 2013 Apr; 17(4):379-92. PubMed ID: 23289445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectins in hematological malignancies.
    Giordano M; Croci DO; Rabinovich GA
    Curr Opin Hematol; 2013 Jul; 20(4):327-35. PubMed ID: 23695449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectins in the tumor endothelium: opportunities for combined cancer therapy.
    Thijssen VL; Poirier F; Baum LG; Griffioen AW
    Blood; 2007 Oct; 110(8):2819-27. PubMed ID: 17591944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated computational analysis of the structure, dynamics, and ligand binding interactions of the human galectin network.
    Guardia CM; Gauto DF; Di Lella S; Rabinovich GA; Martí MA; Estrin DA
    J Chem Inf Model; 2011 Aug; 51(8):1918-30. PubMed ID: 21702482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of galectins in tumor immunity: strategies and methods.
    Cerliani JP; Dalotto-Moreno T; Compagno D; Dergan-Dylon LS; Laderach DJ; Gentilini L; Croci DO; Méndez-Huergo SP; Toscano MA; Salatino M; Rabinovich GA
    Methods Mol Biol; 2015; 1207():249-68. PubMed ID: 25253145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016-present).
    Sethi A; Sanam S; Alvala R; Alvala M
    Expert Opin Ther Pat; 2021 Aug; 31(8):709-721. PubMed ID: 33749494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3--a jack-of-all-trades in cancer.
    Newlaczyl AU; Yu LG
    Cancer Lett; 2011 Dec; 313(2):123-8. PubMed ID: 21974805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-1 and -9 in angiogenesis: a sweet couple.
    Thijssen VL; Griffioen AW
    Glycobiology; 2014 Oct; 24(10):915-20. PubMed ID: 24861051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of galectins in cancer: Biological challenges for their clinical application.
    Laderach DJ; Compagno D
    Front Immunol; 2022; 13():1104625. PubMed ID: 36703969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.